Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Asset Writedowns and Impairment (2022 - 2024)

Historic Asset Writedowns and Impairment for Orthopediatrics (KIDS) over the last 3 years, with Q4 2024 value amounting to $1.8 million.

  • Orthopediatrics' Asset Writedowns and Impairment changed N/A to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.8 million, marking a year-over-year decrease of 3859.38%. This contributed to the annual value of $1.8 million for FY2024, which is 8639.59% up from last year.
  • Orthopediatrics' Asset Writedowns and Impairment amounted to $1.8 million in Q4 2024.
  • Orthopediatrics' Asset Writedowns and Impairment's 5-year high stood at $3.6 million during Q3 2022, with a 5-year trough of $985000.0 in Q3 2023.
  • For the 3-year period, Orthopediatrics' Asset Writedowns and Impairment averaged around $2.1 million, with its median value being $1.8 million (2024).
  • Examining YoY changes over the last 5 years, Orthopediatrics' Asset Writedowns and Impairment showed a top increase of 7270.71% in 2023 and a maximum decrease of 7270.71% in 2023.
  • Orthopediatrics' Asset Writedowns and Impairment (Quarter) stood at $3.6 million in 2022, then crashed by 72.71% to $985000.0 in 2023, then surged by 86.4% to $1.8 million in 2024.
  • Its Asset Writedowns and Impairment was $1.8 million in Q4 2024, compared to $985000.0 in Q3 2023 and $3.6 million in Q3 2022.